D&D Pharmatech Inc.
Clinical-stage biopharma developing GLP-1 therapies for metabolic and neurodegenerative diseases.
347850 | KO
Overview
Corporate Details
- ISIN(s):
- KR7347850000
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 수정구 금토로80번길 27 (금토동, 텔레칩스) 4층, 성남시
- Website:
- http://www.ddpharmatech.com/
- Sector:
- Manufacturing
Description
D&D Pharmatech is a clinical-stage biopharmaceutical company specializing in the development of therapies based on GLP-1 (Glucagon-like peptide-1) and related peptides. The company's pipeline primarily targets metabolic diseases, including obesity and MASH (Metabolic dysfunction-associated steatohepatitis), as well as neurodegenerative disorders. A core competency is its proprietary oral peptide delivery technology. Key candidates in its portfolio include DD01, an injectable dual GLP-1/glucagon receptor agonist for MASH that has received FDA Fast Track Designation, and an oral GLP-1 therapy for obesity. The company operates a global model, funding drug development through specialized subsidiaries, with research functions in Korea and clinical development managed by its US-based team.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-03-13 00:00 |
주주총회소집공고
|
Korean | 194.9 KB | ||
| 2025-03-13 00:00 |
의결권대리행사권유참고서류
|
Korean | 194.2 KB | ||
| 2025-03-13 00:00 |
주주총회집중일개최사유신고
|
Korean | 5.0 KB | ||
| 2025-03-07 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 129.3 KB | ||
| 2025-02-20 00:00 |
[기재정정]주식등의대량보유상황보고서(약식)
|
Korean | 112.0 KB | ||
| 2025-02-13 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.5 KB | ||
| 2025-02-13 00:00 |
주주총회소집결의
|
Korean | 13.9 KB | ||
| 2025-02-10 00:00 |
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2025-02-10 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 84.0 KB | ||
| 2025-01-09 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 67.4 KB | ||
| 2024-12-23 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.4 KB | ||
| 2024-12-13 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.2 KB | ||
| 2024-12-10 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.7 KB | ||
| 2024-12-10 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.7 KB | ||
| 2024-12-10 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.7 KB |
Automate Your Workflow. Get a real-time feed of all D&D Pharmatech Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for D&D Pharmatech Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for D&D Pharmatech Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
